Singer suffers devastating 'side-effect' that can't be reversed after taking Ozempic for one year

A singer has shared the heartbreaking health issues she is facing as a result of taking Ozempic.

Avery is known for songs such as 'Go Screw Yourself (GSY) and 'Meant to Live', but the artist took to social media earlier this year to reveal that after just one year of taking Type-2 diabetes medication Ozempic, she has been left with complications.

In a candid video on Instagram, she said it all 'explains why I’m in pain all the time' after a trip to the doctors'.

The American artist claimed: "I have significant bone loss," adding in the caption that she has 'osteoperosis in some parts' of the body and 'osteopenia' in others.

Osteoperosis is when bones get thinner and weaker, while Ostepenia is to do with bone density loss. However, health professionals have now explained if this is linked to the controversial medication, which has recently been used by a number of celebrities for weight loss.

Doctor Myro, a medical expert with over 879,000 subscribers on YouTube, admitted that people on Ozempic actually get osteoporosis 'all the time'.

But he pointed out: "There currently is no evidence that it's [Ozempic] that's causing that osteoporosis. It is a disease of skinny people, less body weight, less pressure on the bones, less bone density."

He added that when you lose weight in any capacity, you also lose some bone too, along with muscle.

The doctor pointed out: "Doing it without weight training and proper nutrition with lots of protein, huge mistake."

Healthline further state that people that take glucagon-like peptide 1 (GLP-1) drugs such as Ozempic, Wegovy and Mounjaro can experience rapid weight loss.

“According to a clinical trial of Ozempic, after 68 weeks on the medication, 86.4% of participants lost 5% or more of their body weight, and 69.1% lost 10% or more of their body weight,” the website stated.

Losing weight can bring on a number of health benefits, but this can also bring on a decrease in muscle mass and a lower bone density, the health experts explain.

There are still no studies that explicitly link a reduced bone density with GLP-1 drugs, but it is said that significant weight loss can lead to bone loss, which can then lead to Sarcopenia.

Dr Rekha Kumar, an endocrinologist in NYC and Chief Medical Officer of Found, explained to Healthline: "Sarcopenia affects the elderly population and typically is associated with aging. "

"However, rapidly losing weight with GLP-1s like Ozempic or Wegovy without the proper diet and exercise can also cause sarcopenia (sometimes referred to as ‘skinny fat’) at any age," Dr Kumar explained.

He added that 'a lower body weight does not always mean' that someone is healthier, with body composition the most important thing to keep an eye on.

A spokesperson for Novo Nordisk, the company that develops Ozempic, previously told UNILAD: "Novo Nordisk does not condone, suggest, or encourage misuse of any of our medicines outside of their approved indications. Ozempic (semaglutide injection) is not licensed for the treatment of weight loss.

"We understand the health challenges this individual has faced and the safety and wellbeing of patients taking our medicines is our top priority. We strongly recommend that all patients stay in close contact with their healthcare professional for proper diagnosis, ongoing guidance, and careful monitoring."

They continued: "It is important to note that Ozempic (semaglutide injection) is a prescription-only medicine, meaning that it must be prescribed by a healthcare professional under strict supervision.

"Patients must make any decisions about treatment together with their healthcare professional so that their doctor can assess whether it is appropriate to prescribe the medicine or not, based on their assessment of the patient’s individual medical profile.

"Accessing prescription-only medicines without a valid prescription or without the care of a healthcare professional can pose a direct danger to health."